Home/Filings/4/A/0000899243-23-011815
4/A//SEC Filing

Cadoret-Manier Onaiza 4/A

Accession 0000899243-23-011815

CIK 0001851194other

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 5:11 PM ET

Size

6.0 KB

Accession

0000899243-23-011815

Insider Transaction Report

Form 4/AAmended
Period: 2023-01-11
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-11+20,42720,427 total
    Exercise: $34.16Exp: 2033-01-11Common Stock (20,427 underlying)
Footnotes (2)
  • [F1]The Form 4 filed on January 12, 2023, erroneously reported that reporting person received an option award for 12,880 shares on January 11, 2023. The correct option award amount is for 20,427 shares.
  • [F2]One-thirty sixth (1/36th) of the Shares subject to the option will be scheduled to vest each month following the grant date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through the applicable vesting date.

Issuer

Ventyx Biosciences, Inc.

CIK 0001851194

Entity typeother

Related Parties

1
  • filerCIK 0001799355

Filing Metadata

Form type
4/A
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 5:11 PM ET
Size
6.0 KB